Cyclerion Therapeutics (CYCN) Operating Expenses (2019 - 2025)
Historic Operating Expenses for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $1.9 million.
- Cyclerion Therapeutics' Operating Expenses rose 4228.44% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 603.04%. This contributed to the annual value of $5.6 million for FY2024, which is 5654.39% down from last year.
- Per Cyclerion Therapeutics' latest filing, its Operating Expenses stood at $1.9 million for Q3 2025, which was up 4228.44% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Operating Expenses registered a high of $19.2 million during Q2 2021, and its lowest value of $1.3 million during Q4 2024.
- Over the past 5 years, Cyclerion Therapeutics' median Operating Expenses value was $4.5 million (recorded in 2022), while the average stood at $6.6 million.
- Per our database at Business Quant, Cyclerion Therapeutics' Operating Expenses plummeted by 7802.16% in 2024 and then soared by 4228.44% in 2025.
- Cyclerion Therapeutics' Operating Expenses (Quarter) stood at $14.9 million in 2021, then plummeted by 70.04% to $4.5 million in 2022, then crashed by 59.71% to $1.8 million in 2023, then fell by 27.35% to $1.3 million in 2024, then soared by 44.25% to $1.9 million in 2025.
- Its Operating Expenses stands at $1.9 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.5 million for Q1 2025.